Come visit us at the 2017 AAPS NBC in booth #512!
white paper download: validating the simoa technology!
Frontage is the first and only laboratory to validate Quanterix' Simoa HD1 Analyzer for performing immunoassays! Click here to download the White Paper.
a reputation for solving drug development challenges
Frontage helps organizations advance their early phase drug development efforts with extensive scientific and analytical services, including bioanalysis, preclinical, and Phase I-IIa studies and CMC product development. Our services and expert guidance span lead candidate identification in drug discovery through late stage clinical development. Biometrics capabilities support Phase I-IV clinical trials. CMC pharmaceutical development offerings range from organic synthesis to product commercialization support.
A deep understanding of drug development, combined with the skills and commitment to solve complex challenges reinforces our ability to deliver reliable data that provides informed decision making. We work with small and large molecules for novel biopharmaceuticals, as well as generic-equivalent and consumer products.
When you choose Frontage, we promise you a collaborative environment and a broad range of services and expertise delivered by skilled professionals. Our entire organization is geared toward flexibility and responsiveness.
Enroll in a Study | FAQ
Frontage is hosting a series of Bio-Forum events throughout 2017. Our most recent event was held at the end of March in San Francisco, CA. The first event was held in January in Cambridge, MA. We will be hosting additional events in the summer on the East Coast and later in the year on the West Coast. Contact us if you have interest in attending one of these events!
Join Frontage at these upcoming
Trade Shows & Events:
SABPA Biomedical Forum
San Diego, CA on April 29
2017 AAPS National Biotechnology Conference
San Diego, CA from May 1-3, 2017
65th Conference on Mass Spectrometry and Allied Topics
Indianapolis, IN from June 4-8, 2017
SAPA-GP 15th Annual Conference
King og Prussia, PA on June 24, 2017
> A positive outcome from an FDA inspection conducted at Frontage’s Biologics Bioassay Lab! Click here!
>Join us in welcoming Dr. Philip Doren to the Frontage team as the President of Clinical Services. Click here for the announcement.
> Frontage becomes 1st CRO to complete a GLP validation of the Simoa HD-1 Analyzer for Biomarker Analysis and announces Partnership with Quanterix! Read the Press Release here!